Literature DB >> 6664677

The mechanism of betaxolol, a new ocular hypotensive agent.

G R Reiss, R F Brubaker.   

Abstract

A single drop, double-masked study was performed using 1% betaxolol ophthalmic solution in 24 normal subjects. Subjects received one drop of this new drug to one eye and a placebo drop to the fellow eye. Aqueous humor flow was measured using the technique of fluorophotometry, and outflow resistance was measured using tonography. Betaxolol suppressed aqueous humor flow in all individuals. The range of suppression was from 7 to 51%, with a mean suppression of 32 +/- 13%. The drug had no consistent effect on outflow resistance, and no pupillary changes were seen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6664677     DOI: 10.1016/s0161-6420(83)34380-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

1.  Short-term effect of topical brinzolamide-timolol fixed combination on ocular surface of glaucoma patients.

Authors:  Penpe Gul Firat; Emine Samdanci; Selim Doganay; Mufide Cavdar; Nurdan Sahin; Abuzer Gunduz
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

Review 2.  Pharmacological therapy for glaucoma: a review.

Authors:  P F Hoyng; L M van Beek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

Review 3.  Management of glaucoma: focus on pharmacological therapy.

Authors:  Robert E Marquis; Jess T Whitson
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 4.  Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension.

Authors:  M M Buckley; K L Goa; S P Clissold
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

5.  Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.

Authors:  A L Robin
Journal:  Trans Am Ophthalmol Soc       Date:  1996

Review 6.  Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.

Authors:  A M Brooks; W E Gillies
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

7.  Levobetaxolol hydrochloride: a review of its pharmacology and use in the treatment of chronic open-angle glaucoma and ocular hypertension.

Authors:  Luciano Quaranta; Raffaele Turano; Teodoro Pizzolante
Journal:  Clin Ophthalmol       Date:  2007-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.